Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2013 Oct 3;8(10):2345. doi: 10.1021/cb400715w

Correction to Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis

Jessica M Hearn, Isolda Romero-Canelon, Bushra Qamar, Zhe Liu, Ian Hands-Portman, Peter J Sadler
PMCID: PMC3805325

The caption for Figure 5 in the original publication incorrectly stated that data for complexes 14 were shown. It should refer only to data for complex 1. The corrected caption reads as follows:

Figure 5. Bar graph showing the mitochondrial membrane polarization, determined by a reduction in red (FL2) fluorescence, by complex 1 against that of a negative and positive control (5 μM carbonyl cyanide m-chlorophenylhydrazone). p-values were calculated after a Welch t test with the negative control data. Each value is the mean taken from 3 replicates, with error bars for the standard deviation.

Funding Statement

National Institutes of Health, United States


Articles from ACS Chemical Biology are provided here courtesy of American Chemical Society

RESOURCES